{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:59:24Z","timestamp":1787162364332,"version":"build-2736575974"},"reference-count":50,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,8,18]]},"DOI":"10.3233\/jad-200227","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:20:52Z","timestamp":1593526852000},"page":"1375-1389","source":"Crossref","is-referenced-by-count":33,"title":["Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice"],"prefix":"10.1177","volume":"76","author":[{"given":"Yun","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Anesthesiology, Children\u2019s Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Anesthesiology, People\u2019s Hospital of Beijing Daxing District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Anesthesiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matan","family":"Ben Abou","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcheng","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hepner","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc., Woodcliff Lake, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryellen F.","family":"Eckenhoff","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200227_ref1","first-page":"809","article-title":"Prevalence, costs, and treatment of Alzheimer\u2019s disease and related dementia: a managed care perspective","volume":"7","author":"Rice","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.3233\/JAD-200227_ref2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2741\/4285","article-title":"An update on drug treatment options of Alzheimer\u2019s disease","volume":"19","author":"Allgaier","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.3233\/JAD-200227_ref3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0306-4522(99)00042-1","article-title":"Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer\u2019s disease neurofibrillary and beta-amyloid pathologies","volume":"92","author":"Kelliher","year":"1999","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-200227_ref4","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1523\/JNEUROSCI.2047-09.2009","article-title":"Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice","volume":"29","author":"Chakroborty","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200227_ref5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-017-1733-7","article-title":"Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer\u2019s disease-like pathologies and cognitive deficits","volume":"134","author":"Lacampagne","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-200227_ref6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermia","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"10.3233\/JAD-200227_ref7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.3233\/JAD-200227_ref8","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"Zhang","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200227_ref9","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","article-title":"Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease","volume":"32","author":"Oules","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200227_ref10","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jalz.2011.09.141","article-title":"Early and chronic treatment with dantrolene blocked later learning and memory deficits in older Alzheimer\u2019s triple transgenic mice","volume":"7","author":"Peng","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200227_ref11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","article-title":"Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice","volume":"516","author":"Peng","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-200227_ref12","doi-asserted-by":"crossref","first-page":"e52056","DOI":"10.1371\/journal.pone.0052056","article-title":"Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer\u2019s disease","volume":"7","author":"Chakroborty","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-200227_ref13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/jnnp.44.4.334","article-title":"The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration","volume":"44","author":"Meyler","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-200227_ref14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0773.1989.tb00621.x","article-title":"Whole-body autoradiography of 14C-dantrolene in the marmoset monkey","volume":"64","author":"Wuis","year":"1989","journal-title":"Pharmacol Toxicol"},{"key":"10.3233\/JAD-200227_ref15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington\u2019s disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-200227_ref16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J Control Release"},{"key":"10.3233\/JAD-200227_ref17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9 Suppl 3","author":"Hanson","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-200227_ref18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exger.2010.08.026","article-title":"Intranasal insulin as a therapeutic option in the treatment of cognitive impairments","volume":"46","author":"Benedict","year":"2011","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-200227_ref19","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.40.9.1427","article-title":"Dantrolene sodium and hepatic injury","volume":"40","author":"Chan","year":"1990","journal-title":"Neurology"},{"key":"10.3233\/JAD-200227_ref20","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200227_ref21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-143120","article-title":"Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"45","author":"Richard","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200227_ref22","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1016\/j.neurobiolaging.2011.08.006","article-title":"No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Hillmann","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200227_ref23","first-page":"e4440","article-title":"Intranasal administration of CNS therapeutics to awake mice","volume":"74","author":"Hanson","year":"2013","journal-title":"J Vis Exp"},{"key":"10.3233\/JAD-200227_ref24","doi-asserted-by":"crossref","first-page":"e0229156","DOI":"10.1371\/journal.pone.0229156","article-title":"Intranasal administration of dantrolene increased brain concentration and duration","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-200227_ref25","first-page":"8.24","article-title":"Simple behavioral assessment of mouse olfaction","volume":"Chapter 8","author":"Yang","year":"2009","journal-title":"Curr Protoc Neurosci"},{"key":"10.3233\/JAD-200227_ref26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.23536","article-title":"Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory","volume":"71","author":"Zhang","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-200227_ref27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nucmedbio.2014.09.011","article-title":"Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a clinical trial application for a phase I\/II clinical trial of (111)In-BzDTPA-pertuzumab","volume":"42","author":"Lam","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.3233\/JAD-200227_ref28","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1046\/j.1471-4159.1996.67062390.x","article-title":"Dantrolene is cytoprotective in two models of neuronal cell death","volume":"67","author":"Wei","year":"1996","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-200227_ref29","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1213\/ANE.0b013e3181f7181c","article-title":"The cytoprotective effects of dantrolene: a ryanodine receptor antagonist","volume":"111","author":"Inan","year":"2010","journal-title":"Anesth Analg"},{"key":"10.3233\/JAD-200227_ref30","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3","volume":"28","author":"Chen","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200227_ref31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0006-8993(00)03101-2","article-title":"Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice","volume":"888","author":"Nagatomo","year":"2001","journal-title":"Brain Res"},{"key":"10.3233\/JAD-200227_ref32","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00586-009-1033-6","article-title":"Dantrolene can reduce secondary damage after spinal cord injury","volume":"18","author":"Aslan","year":"2009","journal-title":"Eur Spine J"},{"key":"10.3233\/JAD-200227_ref33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JAD-180858","article-title":"Alzheimer\u2019s disease presenilin-1 mutation sensitizes neurons to impaired autophagy flux and propofol neurotoxicity: role of calcium dysregulation","volume":"67","author":"Yang","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200227_ref34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/WAD.0000000000000075","article-title":"Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice","volume":"29","author":"Wu","year":"2015","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-200227_ref35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2018.11.040","article-title":"Harnessing genetic complexity to enhance translatability of Alzheimer\u2019s disease mouse models: a path toward precision medicine","volume":"101","author":"Neuner","year":"2019","journal-title":"Neuron"},{"key":"10.3233\/JAD-200227_ref36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4172\/2161-0460.1000374","article-title":"Calcium dysregulation in Alzheimer\u2019s disease: a target for new drug development","volume":"7","author":"Wang","year":"2017","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.3233\/JAD-200227_ref37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/1871527317666180619162649","article-title":"Dantrolene: from malignant hyperthermia to Alzheimer\u2019s disease","volume":"18","author":"Shi","year":"2019","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.3233\/JAD-200227_ref38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/ALN.0000000000003224","article-title":"Dantrolene ameliorates impaired neurogenesis and synaptogenesis in induced pluripotent stem cell lines derived from patients with Alzheimer\u2019s disease","volume":"132","author":"Wang","year":"2020","journal-title":"Anesthesiology"},{"key":"10.3233\/JAD-200227_ref39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-2009-1151","article-title":"Reexamining Alzheimer\u2019s disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta","volume":"18","author":"Castellani","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200227_ref40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1750-1326-6-85","article-title":"Adult hippocampal neurogenesis and its role in Alzheimer\u2019s disease","volume":"6","author":"Mu","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-200227_ref41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-0186(03)00012-3","article-title":"Dantrolene inhibits NMDA-induced 45Ca uptake in cultured cerebellar granule neurons","volume":"43","author":"Makarewicz","year":"2003","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-200227_ref42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fnins.2010.00194","article-title":"Calcium and neurogenesis in Alzheimer\u2019s disease","volume":"4","author":"Wang","year":"2010","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-200227_ref43","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1523\/JNEUROSCI.4002-14.2015","article-title":"Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer\u2019s disease mice","volume":"35","author":"Chakroborty","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200227_ref44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0361-9230(98)00005-7","article-title":"Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-gamma in endotoxemic mice","volume":"46","author":"Nemeth","year":"1998","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-200227_ref45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jcb.20064","article-title":"Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling","volume":"92","author":"Conrad","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.3233\/JAD-200227_ref46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1471-4159.2000.0750081.x","article-title":"Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression","volume":"75","author":"Wei","year":"2000","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-200227_ref47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-015-0262-3","article-title":"Calcium dysregulation via L-type voltage-dependent calcium channels and ryanodine receptors underlies memory deficits and synaptic dysfunction during chronic neuroinflammation","volume":"12","author":"Hopp","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-200227_ref48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/cvr\/cvw185","article-title":"Inositol 1,4,5-trisphosphate-mediated sarcoplasmic reticulum-mitochondrial crosstalk influences adenosine triphosphate production via mitochondrial Ca2+ uptake through the mitochondrial ryanodine receptor in cardiac myocytes","volume":"112","author":"Seidlmayer","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.3233\/JAD-200227_ref49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-142427","article-title":"Calcium signaling, excitability, and synaptic plasticity defects in a mouse model of Alzheimer\u2019s disease","volume":"45","author":"Zhang","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200227_ref50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11427-011-4205-7","article-title":"Early calcium dysregulation in Alzheimer\u2019s disease: setting the stage for synaptic dysfunction","volume":"54","author":"Chakroborty","year":"2011","journal-title":"Sci China Life Sci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:30Z","timestamp":1777370910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200227"}},"subtitle":[],"editor":[{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":50,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-200227","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]}}}